Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

FDA grants orphan drug designation to AbbVie's atrasentan

Oct. 5, 2016

Dimerix reports positive safety data for phase II trial of DMX-200

Oct. 5, 2016

twoXAR collaborates with Mount Sinai researchers in diabetic nephropathy

Oct. 5, 2016

Peloton Therapeutics describes HIF-2alpha inhibitors

Sep. 26, 2016

Astellas Pharma and Kotobuki Pharmaceutical patent agents for nocturia

Sep. 23, 2016

Regulus begins phase II trial of RG-012 in Alport syndrome

Sep. 22, 2016

Bayer and Evotec establish 5-year research partnership in kidney disease

Sep. 22, 2016

Promising phase II topline results for sparsentan in focal segmental glomerulosclerosis

Sep. 8, 2016

Aquinox initiates phase III study of AQX-1125 for interstitial cystitis/bladder pain syndrome

Sep. 7, 2016

Nymox's fexapotide shows clinically meaningful benefits in BPH

Aug. 31, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...